Sierra Oncology (NASDAQ:SRRA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The brokerage currently has a $61.00 target price on the biotechnology company’s stock. Zacks Investment Research‘s price objective indicates a potential upside […]
Sierra Oncology (NASDAQ:SRRA – Get Rating) was downgraded by investment analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued on Wednesday, The Fly reports. They currently have a $55.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 0.60% […]
Wall Street brokerages expect that Sierra Oncology, Inc. (NASDAQ:SRRA – Get Rating) will post earnings of ($0.91) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Sierra Oncology’s earnings. The lowest EPS estimate is ($0.97) and the highest is ($0.85). Sierra Oncology reported earnings per share of […]
Sierra Oncology, Inc. (NASDAQ:SRRA – Get Rating) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 1,090,000 shares, a growth of 26.4% from the February 13th total of 862,600 shares. Based on an average daily trading volume, of 1,120,000 shares, the days-to-cover ratio […]
Oppenheimer Brokers Cut Earnings Estimates for Sierra Oncology, Inc (NASDAQ:SRRA) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.